In a regulatory filing, iBio (IBIO) disclosed that its director Antonio Parada bought 183.8K shares of common stock on January 10th in a total transaction size of $500K. Shares of iBio are up 11% afterhours at $2.75.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBIO:
- iBio closes private placement offering with board members, officers
- iBio Advances Antibody Development for Obesity Treatment
- iBio, AstralBio announce development of antibody inhibiting Activin E
- iBio Expands Pipeline with New Antibody Agreement
- iBio expands cardiometabolic, obesity treatment development program